Taro Pharmaceuticals U.S.A., Inc. recalls Taro Pharmaceuticals — Lamotrigine Tablets, USP 100mg
- Recall date
- January 10, 2020
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Taro Pharmaceuticals U.S.A., Inc., Taro Pharmaceuticals
Why it was recalled
Cross contamination with another drug substance, Enalapril Maleate — Unapproved Ingredient
What was recalled
Lamotrigine Tablets, USP 100mg
Read the official recall notice →
Get recall alerts
Free email alert whenever Taro Pharmaceuticals U.S.A., Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Taro Pharmaceuticals U.S.A., Inc., Taro Pharmaceuticals